Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiationSalicylic acid-independent ENHANCED DISEASE SUSCEPTIBILITY1 signaling in Arabidopsis immunity and cell death is regulated by the monooxygenase FMO1 and the Nudix hydrolase NUDT7Regulatory dendritic cells: there is more than just immune activationIn vivo expansion of naïve CD4+ CD25(high) FOXP3+ regulatory T cells in patients with colorectal carcinoma after IL-2 administrationMacrophage activation and polarization: nomenclature and experimental guidelinesVav1 regulates MHCII expression in murine resting and activated B cells.Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction.CASPAR: a hierarchical bayesian approach to predict survival times in cancer from gene expression data.IlluminaGUI: graphical user interface for analyzing gene expression data generated on the Illumina platform.Autoantibodies frequently detected in patients with aplastic anemia.The development of a comparison approach for Illumina bead chips unravels unexpected challenges applying newest generation microarrays.Minimal residual disease detection after myeloablative chemotherapy in chronic lymphatic leukemia.Why do B cell lymphoma fail to elicit clinically sufficient T cell immune responses?T cell mediated immunotherapy for B cell lymphoma.High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3.Global transcriptional profiles of beating clusters derived from human induced pluripotent stem cells and embryonic stem cells are highly similarA stimulating new target for cancer immunotherapy.Follicular lymphomas can be induced to present alloantigen efficiently: a conceptual model to improve their tumor immunogenicity.miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia.Ear2 deletion causes early memory and learning deficits in APP/PS1 mice.Expression of a neuroendocrine gene signature in gastric tumor cells from CEA 424-SV40 large T antigen-transgenic mice depends on SV40 large T antigen.Tumour immunotherapy: new tools, new treatment modalities and new T-cell antigens.Lack of PPARγ in myeloid cells confers resistance to Listeria monocytogenes infection.From cancer genomics to cancer immunotherapy: toward second-generation tumor antigens.High-resolution transcriptome of human macrophages.Regulatory T cells in cancer.Linking genomics to immunotherapy by reverse immunology--'immunomics' in the new millennium.Transcriptome-based network analysis reveals a spectrum model of human macrophage activation.Influence of genomics on cancer vaccine development from guess to prediction.Transcriptional profiling reveals progeroid Ercc1(-/Δ) mice as a model system for glomerular aging.From genomics to cancer vaccines: patient-tailored or universal vaccines?RNA-stabilized whole blood samples but not peripheral blood mononuclear cells can be stored for prolonged time periods prior to transcriptome analysis.Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infectionComparative approach to define increased regulatory T cells in different cancer subtypes by combined assessment of CD127 and FOXP3.CD40 activation: potential for specific immunotherapy in B-CLL.Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells.DCs in lymphoma--biology and therapeutic aspects.Human non-germinal center B cell interleukin (IL)-12 production is primarily regulated by T cell signals CD40 ligand, interferon gamma, and IL-10: role of B cells in the maintenance of T cell responses.DCs and CD40-activated B cells: current and future avenues to cellular cancer immunotherapy.Prediction and prognosis: impact of gene expression profiling in personalized treatment of breast cancer patients
P50
Q24314914-DAD52CA0-4B36-4D28-856C-49F42BE57C14Q24542387-1DC9F30C-DCEA-46D8-A998-1357E1897514Q28388235-D42E9EE3-5D6D-403D-8E58-E1FA18F3E465Q28732675-F60DF8BF-800D-46FC-923F-08FE6D358FF5Q29620642-CF1FBBC2-67BD-4707-BDCA-6DF5DAE5FC4FQ30426923-3CA4724E-B6E1-49C6-9FE7-826E21B70C56Q30894063-12403903-2A0D-4532-81E8-4F1141C0FD9CQ31034872-008DD360-141D-4D0A-A8FF-492DD1A855ADQ31106813-97D2AFF1-B0B5-4103-B7CA-B258D4B36FCCQ31155251-9F83DBBB-FBAC-4789-9B1B-A9C2A584B93BQ33470683-7C958F4B-2EAC-4318-BCD1-285AF44B81A7Q33534354-F4033C9C-6346-409F-B606-5B18365A05D6Q33536297-60E95A88-BFC0-4B6A-9F0D-E308ED0DDD8FQ33544631-FBA1AD60-04BB-430B-8E6A-44D0D28EBA85Q33565025-BEFCDF3B-0740-471B-97E6-B27C9E82B32AQ33693259-DA7EAEA5-B622-43EB-A9CB-701F50D037F3Q33751521-E9FD07D6-AEC7-4C95-9BAE-E960553F7BD1Q33956237-8DDCAA22-F995-4CB4-B9C7-926A78C6F945Q34079123-DC8C3439-B726-4FF8-93C5-D6FEC048B3BEQ34101988-62AD2574-6D2D-4A52-9E64-7D610DDD5F09Q34130710-B0EF2A15-FC0F-4FFD-8B2B-E47DD012B2E3Q34265381-EC9FFC01-E767-40A3-A121-CB8AA6E8789DQ34281850-5FDB7910-EC23-4783-BE2F-2F5488D3F12DQ34348874-BD1FDA23-3B19-4FA7-92C0-0F71231AFB2EQ34429127-A0101E30-2136-4755-8220-1E2565A3C33CQ34550248-3263D93A-A5CD-4B6F-B8FB-292F20E60FDEQ34567330-AC787882-8A29-471A-914A-BD477655044BQ34659689-05C4E4C4-2982-4DF9-B9CB-2ED74583BC64Q34779994-E8D084E7-7CDC-41E5-806A-020AADDB3A27Q34943024-07049CDA-5EA8-4EED-A762-C727BBFFDDCFQ35069797-F4A4CA11-11D8-4FD2-B715-27183DFAD318Q35069942-E275D0CB-E9B6-4A56-9AEC-CC55B72615B2Q35131219-9CD2E7F0-0581-423B-95FF-ED09F0588AEBQ35195777-605D72B0-134F-4B6C-B9FC-618D03E3D4DBQ35777555-C4C8E645-FB18-462E-B772-450D2BDEE481Q35788898-3B152A7C-69A8-4A03-9D92-7BA155EA70E4Q35809288-7187C5F2-9193-48C3-A7C0-0F087A025997Q35834633-78B4C108-E6AC-4CB4-9167-4D9501B9FD3DQ35941917-940E3353-38A1-457E-8970-FFA3A132F9F1Q36117673-2F63E3D6-4B75-4089-AB34-C2368FEE0760
P50
description
Duits klinische genetica
@nl
German geneticist
@en
German geneticist
@en-ca
German geneticist
@en-gb
deutscher Immunologe, Krebs- und Genomforscher
@de
genetista alemán
@es
géineolaí Gearmánach
@ga
professor académico alemão
@pt
tysk professor
@da
tysk professor
@sv
name
Joachim Schultze
@ast
Joachim Schultze
@ca
Joachim Schultze
@da
Joachim Schultze
@de
Joachim Schultze
@en
Joachim Schultze
@es
Joachim Schultze
@fr
Joachim Schultze
@nb
Joachim Schultze
@nds
Joachim Schultze
@nl
type
label
Joachim Schultze
@ast
Joachim Schultze
@ca
Joachim Schultze
@da
Joachim Schultze
@de
Joachim Schultze
@en
Joachim Schultze
@es
Joachim Schultze
@fr
Joachim Schultze
@nb
Joachim Schultze
@nds
Joachim Schultze
@nl
altLabel
Joachim L. Schultze
@de
prefLabel
Joachim Schultze
@ast
Joachim Schultze
@ca
Joachim Schultze
@da
Joachim Schultze
@de
Joachim Schultze
@en
Joachim Schultze
@es
Joachim Schultze
@fr
Joachim Schultze
@nb
Joachim Schultze
@nds
Joachim Schultze
@nl
P227
P1053
D-7794-2011
P1412
P1559
Joachim Schultze
@de
P21
P214
6278151965379700470004
P227
1152978977
P31
P3829
P496
0000-0003-2812-9853
P569
1965-04-30T00:00:00Z
P734
P735
P7859
viaf-6278151965379700470004